Questions about the efficacy of antidepressantdrugs in depression have beenraised as a result of 2 recent reports.Turner et al. reviewed industry-sponsoredclinical trials (randomized controlled trials;RCTs) submitted to the FDA and foundthat positive RCTs were more likely to besubsequently published than negative trials.The authors suggested that publisheddata overestimate the effectiveness of antidepressants.
Please sign in or purchase this PDF for $40.00.
Save
Cite